← Back to Search

Very Low Carbohydrate Diet for Type 1 Diabetes

N/A
Recruiting
Led By Belinda Lennerz
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 to 40 years
Males and females with T1D for at least 1 year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 5-12 on the very low carbohydrate diet
Awards & highlights

Study Summary

This trial will study whether a very-low-carbohydrate diet results in an adequate response to glucagon in young adults with type 1 diabetes.

Who is the study for?
This trial is for adults aged 18-40 with Type 1 Diabetes who have been managing their condition for at least a year, attend regular diabetes care visits, and use a continuous glucose monitor and insulin pump. They should have a BMI of 18.5-35 kg/m2 and stable glycemic control. Those pregnant, on restrictive diets, with significant illnesses or psychiatric conditions, substance abuse issues, recent severe diabetic complications or certain dietary restrictions cannot participate.Check my eligibility
What is being tested?
The study tests the effectiveness of a Very Low Carbohydrate Diet (VLC) in maintaining adequate glucagon response during hypoglycemia in people with Type 1 Diabetes over a longer term (12 weeks). Participants will be randomly assigned to either follow the VLC diet or standard diet and then undergo controlled testing involving induced low blood sugar followed by glucagon injection.See study design
What are the potential side effects?
Potential side effects may include risks associated with very low carbohydrate intake such as nutrient deficiencies if not properly managed. The intervention could also affect how the body responds to glucagon when blood sugar is low after prolonged carbohydrate restriction.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 40 years old.
Select...
I have had Type 1 Diabetes for at least one year.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 5-12 on the very low carbohydrate diet
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 5-12 on the very low carbohydrate diet for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucagon treatment success, defined as an increase in glucose level to ≥ 70 mg/dL or an Increase of ≥ 20 mg/dL from glucose nadir within 30 minutes after receiving 1 mg glucagon IM
Secondary outcome measures
Plasma glucose levels following glucagon administration
Plasma levels of beta-hydroxybutyrate following glucagon administration
Plasma levels of free fatty acids following glucagon administration
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Very low carbohydrate dietExperimental Treatment1 Intervention
Dietary Intervention, food delivery

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor
769 Previous Clinical Trials
5,580,517 Total Patients Enrolled
Belinda LennerzPrincipal Investigator - Boston Children's Hospital
Boston Children's Hospital
2 Previous Clinical Trials
392 Total Patients Enrolled
Belinda S LennerzPrincipal InvestigatorBoston Children's Hospital

Media Library

Very low carbohydrate diet Clinical Trial Eligibility Overview. Trial Name: NCT04200391 — N/A
Type 1 Diabetes Research Study Groups: Very low carbohydrate diet
Type 1 Diabetes Clinical Trial 2023: Very low carbohydrate diet Highlights & Side Effects. Trial Name: NCT04200391 — N/A
Very low carbohydrate diet 2023 Treatment Timeline for Medical Study. Trial Name: NCT04200391 — N/A
~0 spots leftby Jul 2024